메뉴 건너뛰기




Volumn 150, Issue 3, 2000, Pages 237-243

Zotepine in the prevention of recurrence: A randomised, double-blind, placebo-controlled study for chronic schizophrenia

Author keywords

Clinical trial; Ecurrence; Lacebo controlled; Schizophrenia; Zotepine

Indexed keywords

ZOTEPINE;

EID: 0033924124     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000452     Document Type: Article
Times cited : (54)

References (24)
  • 2
    • 0019155523 scopus 로고
    • Differential effects of amphetamine and neuroleptics on negative vs. Positive symptoms in schizophrenia
    • Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 72:17-19
    • (1980) Psychopharmacology , vol.72 , pp. 17-19
    • Angrist, B.1    Rotrosen, J.2    Gershon, S.3
  • 3
    • 0019155756 scopus 로고
    • What is the best maintenance dose of neuroleptics in schizophrenia?
    • Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatry Res 3:115-122
    • (1980) Psychiatry Res , vol.3 , pp. 115-122
    • Baldessarini, R.J.1    Davis, J.M.2
  • 4
    • 0030065502 scopus 로고    scopus 로고
    • Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial
    • Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S and the olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:97-104
    • (1996) Neuropsychopharmacology , vol.14 , pp. 97-104
    • Beasley, C.M.1    Tollefson, G.2    Tran, P.3    Satterlee, W.4    Sanger, T.5    Hamilton, S.6
  • 5
    • 0028789388 scopus 로고
    • Risperidone in the treatment of negative symptoms of schizophrenia:A meta-analysis
    • Carman J, Peuskens J, Vangeneugden A (1995) Risperidone in the treatment of negative symptoms of schizophrenia:a meta-analysis. Int Clin Psychopharmacol 10:207-213
    • (1995) Int Clin Psychopharmacol , vol.10 , pp. 207-213
    • Carman, J.1    Peuskens, J.2    Vangeneugden, A.3
  • 6
    • 0002983898 scopus 로고
    • Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia
    • Schultz SC, Tamminga CT (eds), Oxford Press, New York
    • Carpenter WT, Buchanon RW (1989) Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia. In: Schultz SC, Tamminga CT (eds) Schizophrenia: scientific progress. Oxford Press, New York
    • (1989) Schizophrenia: Scientific Progress
    • Carpenter, W.T.1    Buchanon, R.W.2
  • 7
    • 0025975251 scopus 로고
    • Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia
    • Casey DE (1991) Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Schizophrenia Res 4:109-120
    • (1991) Schizophrenia Res , vol.4 , pp. 109-120
    • Casey, D.E.1
  • 8
    • 10544243792 scopus 로고    scopus 로고
    • Side effect profiles of new antipsychotic agents
    • Casey DE (1996) Side effect profiles of new antipsychotic agents. J Clin Psychiatry 57:40-45
    • (1996) J Clin Psychiatry , vol.57 , pp. 40-45
    • Casey, D.E.1
  • 9
    • 0001929571 scopus 로고
    • Drugs in the treatment of psychosis: Controlled studies
    • Solomon P (ed), Grune and Stratton, New York
    • Cole JO, Goldberg C, Davis JM (1966) Drugs in the treatment of psychosis: controlled studies. In: Solomon P (ed) Psychiatric drugs. Grune and Stratton, New York, pp 153-180
    • (1966) Psychiatric Drugs , pp. 153-180
    • Cole, J.O.1    Goldberg, C.2    Davis, J.M.3
  • 10
    • 0001584620 scopus 로고    scopus 로고
    • A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia
    • Cooper SJ, Tweed J, Raniwalla J, Butler A (2000) A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatr Scand 101:218-225
    • (2000) Acta Psychiatr Scand , vol.101 , pp. 218-225
    • Cooper, S.J.1    Tweed, J.2    Raniwalla, J.3    Butler, A.4
  • 11
    • 0016765907 scopus 로고
    • Overview: Maintenance therapy in psychiatry, I: Schizophrenia
    • Davis JM (1975) Overview: maintenance therapy in psychiatry, I: schizophrenia. Am J Psychiatry 132:1237-1245
    • (1975) Am J Psychiatry , vol.132 , pp. 1237-1245
    • Davis, J.M.1
  • 13
    • 0024405884 scopus 로고
    • The positive-negative distinction in drug-free schizophrenic patients: Stability, response to neuroleptics, and prognostic significance
    • Kay SR, Singh MM (1989) The positive-negative distinction in drug-free schizophrenic patients: stability, response to neuroleptics, and prognostic significance. Arch Gen Psychiatry 46:711-718
    • (1989) Arch Gen Psychiatry , vol.46 , pp. 711-718
    • Kay, S.R.1    Singh, M.M.2
  • 15
    • 0027318059 scopus 로고
    • Interaction of antipsychotic drugs with neuro-transmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors
    • Leysen JE, Janssen PMF, Schotte A, Luyten WHML, Megens AAHP (1993) Interaction of antipsychotic drugs with neuro-transmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology 112:S40-S54
    • (1993) Psychopharmacology , vol.112
    • Leysen, J.E.1    Janssen, P.M.F.2    Schotte, A.3    Luyten, W.H.M.L.4    Megens, A.A.H.P.5
  • 16
  • 17
    • 0029886798 scopus 로고    scopus 로고
    • Zotepine: Preclinical tests predict antipsychotic efficacy and an atypical profile
    • Needham PL, Atkinson J, Skill MJ, Heal DJ (1996) Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile. Psychopharmacol Bull 32:123-128
    • (1996) Psychopharmacol Bull , vol.32 , pp. 123-128
    • Needham, P.L.1    Atkinson, J.2    Skill, M.J.3    Heal, D.J.4
  • 18
    • 0029889665 scopus 로고    scopus 로고
    • A comparison of an atypical antipsychotic, zotepine, versus haloperidol in patients with acute exacerbation of schizophrenia
    • Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F (1996) A comparison of an atypical antipsychotic, zotepine, versus haloperidol in patients with acute exacerbation of schizophrenia. Psychopharmacol Bull 32:81-88
    • (1996) Psychopharmacol Bull , vol.32 , pp. 81-88
    • Petit, M.1    Raniwalla, J.2    Tweed, J.3    Leutenegger, E.4    Dollfus, S.5    Kelly, F.6
  • 21
    • 0031836975 scopus 로고    scopus 로고
    • Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses
    • Tran PV, Dellva HA, Tollefson GD, Wentley AL, Beasley CM Jr (1998) Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses. Br J Psychiatry 172:499-505
    • (1998) Br J Psychiatry , vol.172 , pp. 499-505
    • Tran, P.V.1    Dellva, H.A.2    Tollefson, G.D.3    Wentley, A.L.4    Beasley C.M., Jr.5
  • 22
    • 0023232864 scopus 로고
    • Behavioural toxicity of antipsychotic drugs
    • Van Putten T, Marder SR (1987) Behavioural toxicity of antipsychotic drugs. J Clin Psychiatry 48[suppl]:13-19
    • (1987) J Clin Psychiatry , vol.48 , Issue.SUPPL. , pp. 13-19
    • Van Putten, T.1    Marder, S.R.2
  • 24
    • 0029985119 scopus 로고    scopus 로고
    • Atypical antipsychotic drugs and long-term outcome in schizophrenia
    • Weiden P, Aquila R, Standard J (1996) Atypical antipsychotic drugs and long-term outcome in schizophrenia. J Clin Psychiatry 57[Suppl 11]:53-60
    • (1996) J Clin Psychiatry , vol.57 , Issue.SUPPL. 11 , pp. 53-60
    • Weiden, P.1    Aquila, R.2    Standard, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.